Oxford Covid vaccine has 10% efficacy against South African variant, study suggests
Source: The Guardian.
The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested.
Scientists who conducted a small-scale trial of the vaccines efficacy said it showed very little protection against mild to moderate infection, though they expressed hope that in theory it would still offer significant protection against more serious infection.
South Africa has halted the rollout of the Oxford/AstraZeneca jab, while a UK health minister indicated that an annual Covid jab could become the norm for many people as scientists work to stay a step ahead of the viruss mutations.
Read more: https://www.theguardian.com/world/2021/feb/08/oxford-covid-vaccine-10-effective-south-african-variant-study
Brown Feather
(71 posts)How effective will vaccination actually be? Will we have to line up monthly to get a new shot? Another question is can vaccine maker's even keep up developing new vaccines every couple of months?
LymphocyteLover
(5,662 posts)there's only so much that receptor can mutate and still infect properly, but the vaccine may need to be modified a bit as we go along
Response to LymphocyteLover (Reply #3)
Name removed Message auto-removed
bullimiami
(13,111 posts)LymphocyteLover
(5,662 posts)The Mouth
(3,169 posts)will be added to the yearly flu shot.
mucifer
(23,597 posts)Researchers at New York University tested how well the variant of the virus could be destroyed by the blood of 10 people who had received Pfizer's jab.
They found the immune antibodies made by the vaccine were still able to neutralise destroy the coronavirus, but the body didn't make as many of them.
https://www.dailymail.co.uk/news/article-9236097/Pfizers-Covid-vaccine-work-against-South-African-variant-study-says.html
Initech
(100,128 posts)Meanwhile, Novavax, whose vaccine is still in development, said it will start work on a new vaccine to target the South African variant. Pfizer, whose vaccine has been in wide circulation since December, said it doesnt think a new vaccine is necessary at this time.
The companies announced their testing results as the United States first two cases of the South African variant were detected this week in South Carolina. The U.K. variant has been found in at least 26 states. Both variants appear to be more contagious than the original novel coronavirus.
A Pfizer news release said laboratory studies show its vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants.
The vaccine was slightly less effective against the South African variant, the news release said, but Pfizer and its European partner BioNTech believe the small differences in viral neutralization observed in these studies are unlikely to lead to a significant reduction in the effectiveness of the vaccine.
Pfizer said it doesnt think a new kind of vaccine is necessary to battle the variants, but if theres evidence the variants are resistant to the vaccine, it will do so.
https://www.webmd.com/vaccines/covid-19-vaccine/news/20210131/vaccine-not-as-effective-against-south-african-variant
So they'll work and be adjusted as needed to combat new variants. It looks like we'll need booster shots every year.
Talitha
(6,635 posts)(Leaving the house in about 1/2 hour to get my 1st shot.)
Zipgun
(184 posts)video that addresses it to some extent. He had a video that went in to several vaccines and their response to current variants a couple days ago. All helped, but none were as effective.